BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE. COVID-19 and plasma cells: Is there long-lived protection? Immunol Rev 2022. [PMID: 35801537 DOI: 10.1111/imr.13115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cimas FJ, Torres J, Ontañón J, de Cabo C, Lozano J, Requena MÁ, Blas J, Rodríguez-garcía JL, Mas A, Solera J. Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1097747] [Reference Citation Analysis]
2 Kardava L, Buckner CM, Moir S. B-Cell Responses to Sars-Cov-2 mRNA Vaccines. Pathog Immun 2022;7:93-119. [PMID: 36655200 DOI: 10.20411/pai.v7i2.550] [Reference Citation Analysis]
3 Mendez-cortina Y, Rodriguez-perea AL, Chvatal-medina M, Lopera TJ, Alvarez-mesa N, Rodas-marín JK, Moncada DC, Rugeles MT, Velilla PA. Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1007068] [Reference Citation Analysis]
4 Baklaushev VP, Yusubalieva GM, Bychinin MV, Yusubalieva SM, Kalsin VA, Troitskiy AV. A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains. Journal of Clinical Practice 2022;13:43-55. [DOI: 10.17816/clinpract111120] [Reference Citation Analysis]
5 Beerman JT, Beaumont GG, Giabbanelli PJ. A Scoping Review of Three Dimensions for Long-Term COVID-19 Vaccination Models: Hybrid Immunity, Individual Drivers of Vaccinal Choice, and Human Errors. Vaccines (Basel) 2022;10:1716. [PMID: 36298581 DOI: 10.3390/vaccines10101716] [Reference Citation Analysis]
6 Pepper M. Immunity to SARS-CoV-2 infection. Immunol Rev 2022. [PMID: 35836369 DOI: 10.1111/imr.13117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]